TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ:TGTX) today announced its financial results for the third quarter ended September 30, 2022 and recent company developments, along with a business outlook for the remainder of 2022.
Related news for (TGTX)
- Innovation Ignites, Buybacks Surge, and Macy’s Delivers a Retail Revival
- TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
- TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
- TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update